v3.25.2
Intangible assets (Details)
12 Months Ended
Dec. 31, 2024
EUR (€)
€ / shares
IfrsStatementLineItems [Line Items]  
Initial recognition € 65,000,000
Revaluation of price per share | € / shares € 0.00
fair value of the intangible asset € 65,000,000
Breast Check IP Rights [Member]  
IfrsStatementLineItems [Line Items]  
Initial recognition € 60,000,000
Revaluation of price per share | € / shares € 0.00
fair value of the intangible asset € 60,000,000
Tricos IP Rights [Member]  
IfrsStatementLineItems [Line Items]  
Initial recognition € 1,000,000
Revaluation of price per share | € / shares € 0.00
fair value of the intangible asset € 1,000,000
Testic IP Rights [Member]  
IfrsStatementLineItems [Line Items]  
Initial recognition € 1,000,000
Revaluation of price per share | € / shares € 0.00
fair value of the intangible asset € 1,000,000
Davion Masks IP Rights [Member]  
IfrsStatementLineItems [Line Items]  
Initial recognition € 1,500,000
Revaluation of price per share | € / shares € 0.00
fair value of the intangible asset € 1,500,000
Bio-Genex IP Rights [Member]  
IfrsStatementLineItems [Line Items]  
Initial recognition € 1,000,000
Revaluation of price per share | € / shares € 0.00
fair value of the intangible asset € 1,000,000
Merit IP Rights [Member]  
IfrsStatementLineItems [Line Items]  
Initial recognition € 500,000
Revaluation of price per share | € / shares € 0.00
fair value of the intangible asset € 500,000